Histamine H3 receptors, the complex interaction with dopamine and its implications for addiction

British Journal of Pharmacology

Volumn 170, Issue 1, 2013, Pages 46-57

  Ellenbroek, B A ^a  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

cocaine; D1 receptors; D2 receptors; direct pathway; dorsal striatum; drugs of abuse; H3 receptors; histamine; indirect pathway; psychostimulants; ventral striatum

Indexed keywords

DOPAMINE; HISTAMINE; HISTAMINE H3 RECEPTOR; HISTAMINE RECEPTOR;

DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; DRUG CHOICE; DRUG DEPENDENCE; DRUG SEEKING BEHAVIOR; HUMAN; MOLECULAR INTERACTION; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SPECIES DIFFERENCE; STRAIN DIFFERENCE;

COCAINE; D1 RECEPTORS; D2 RECEPTORS; DIRECT PATHWAY; DORSAL STRIATUM; DRUGS OF ABUSE; H3 RECEPTORS; HISTAMINE; INDIRECT PATHWAY; PSYCHOSTIMULANTS; VENTRAL STRIATUM;

ANIMALS; BEHAVIOR, ADDICTIVE; CORPUS STRIATUM; DOPAMINE; HISTAMINE; HISTAMINE RELEASE; HUMANS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, HISTAMINE H3; SUBSTANCE-RELATED DISORDERS; SYNAPTIC TRANSMISSION;

EID: 84881636578     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12221     Document Type: Review

References (113)

1. Alexander SPH, Mathie A, Peters JA, (2011). Guide to receptors and channels (GRAC), 5th Edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
2. Adinoff B, (2004). Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry 12: 305-320.
3. Akhtar M, Uma Devi P, Ali A, Pillai KK, Vohora D, (2006). Antipsychotic-like profile of thioperamide, a selective H3-receptor antagonist in mice. Fundam Clin Pharmacol 20: 373-378.
4. Alleweireldt AT, Kirschner KF, Blake CB, Neisewander JL, (2003). D1-receptor drugs and cocaine-seeking behavior: investigation of receptor mediation and behavioral disruption in rats. Psychopharmacology (Berl) 168: 109-117.
5. Anichtchik OV, Peitsaro N, Rinne JO, Kalimo H, Panula P, (2001). Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease. Neurobiol Dis 8: 707-716.
6. Arias-Montano JA, (2007). Histamine H3 receptors and their role in basal ganglia physiology and pathophysiology. Signal Transduct 7: 364-371.
7. Arias-Montano JA, Floran B, Garcia M, Aceves J, Young JM, (2001). Histamine H3 receptor-mediated inhibition of depolarization-induced, dopamine D1 receptor-dependent release of [3H]-gamma-aminobutyric acid from striatal slices. Br J Pharmacol 133: 165-171.
8. Arrang JM, Garbarg M, Schwartz JC, (1983). Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302: 832-837.
9. Ballesteros-Yanez I, Valverde O, Ledent C, Maldonado R, DeFelipe J, (2007). Chronic cocaine treatment alters dendritic arborization in the adult motor cortex through A CB1 cannabinoid receptor-dependent mechanism. Neuroscience 146: 1536-1545.
10. Beninger RJ, Miller R, (1998). Dopamine D1-like receptors and reward-related incentive learning. Neurosci Biobehav Rev 22: 335-345.
11. Bergman J, Kamien JB, Spealman RD, (1990). Antagonism of cocaine self-administration by selective dopamine D(1) and D(2) antagonists. Behav Pharmacol 1: 355-363.
12. Blandina P, Giorgetti M, Bartolini L, Cecchi M, Timmerman H, Leurs R, et al. (1996). Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats. Br J Pharmacol 119: 1656-1664.
13. Bongers G, Sallmenj T, Passani MB, Mariottini C, Wendelin D, Lozada A, et al. (2007). The Akt/GSK-3 beta axis as a new signaling pathway of the histamine H(3) receptor. J Neurochem 103: 248-258.
14. Bossert JM, Poles GC, Wihbey KA, Koya E, Shaham Y, (2007). Differential effects of blockade of dopamine D1-family receptors in nucleus accumbens core or shell on reinstatement of heroin seeking induced by contextual and discrete cues. J Neurosci 27: 12655-12663.
15. Brabant C, Charlier Y, Quertemont E, Tirelli E, (2005). The H3 antagonist thioperamide reveals conditioned preference for a context associated with an inactive small dose of cocaine in C57BL/6J mice. Behav Brain Res 160: 161-168.
16. Brabant C, Quertemont E, Tirelli E, (2006). Effects of the H3-receptor inverse agonist thioperamide on the psychomotor effects induced by acutely and repeatedly given cocaine in C57BL/6J mice. Pharmacol Biochem Behav 83: 561-569.
17. Brabant C, Alleva L, Grisar T, Quertemont E, Lakaye B, Ohtsu H, et al. (2009). Effects of the H3 receptor inverse agonist thioperamide on cocaine-induced locomotion in mice: role of the histaminergic system and potential pharmacokinetic interactions. Psychopharmacology (Berl) 202: 673-687.
18. Brennan KA, Carati C, Lea RA, Fitzmaurice PS, Schenk S, (2009). Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats. Behav Pharmacol 20: 688-694.
19. Breunig E, Michel K, Zeller F, Seidl S, Weyhern CW, Schemann M, (2007). Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors. J Physiol 583 (Pt 2): 731-742.
20. vandenBrink W, (2012). Evidence-based pharmacological treatment of substance use disorders and pathological gambling. Curr Drug Abuse Rev 5: 3-31.
21. Brown RE, Reymann KG, (1996). Histamine H3 receptor-mediated depression of synaptic transmission in the dentate gyrus of the rat in vitro. J Physiol 496 (Pt 1): 175-184.
22. Caine SB, Thomsen M, Gabriel KI, Berkowitz JS, Gold LH, Koob GF, et al. (2007). Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice. J Neurosci 27: 13140-13150.
23. Carati C, Schenk S, (2011). Role of dopamine D1- and D2-like receptor mechanisms in drug-seeking following methamphetamine self-administration in rats. Pharmacol Biochem Behav 98: 449-454.
24. Chan NY, Robador PA, Levi R, (2012). Natriuretic peptide-induced catecholamine release from cardiac sympathetic neurons: inhibition by histamine H3 and H4 receptor activation. J Pharmacol Exp Ther 343: 568-577.
25. Chiodo LA, Bannon MJ, Grace AA, Roth RH, Bunney BS, (1984). Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience 12: 1-16.
26. Connelly WM, Shenton FC, Lethbridge N, Leurs R, Waldvogel HJ, Faull RL, et al. (2009). The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS. Br J Pharmacol 157: 55-63.
27. Crombag HS, Gorny G, Li Y, Kolb B, Robinson TE, (2005). Opposite effects of amphetamine self-administration experience on dendritic spines in the medial and orbital prefrontal cortex. Cereb Cortex 15: 341-348.
28. Dale HH, Laidlaw PP, (1910). The physiological action of beta-iminazolylethylamine. J Physiol 41: 318-344.
29. Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Laane K, et al. (2007). Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315: 1267-1270.
30. Dalley JW, Everitt BJ, Robbins TW, (2011). Impulsivity, compulsivity, and top-down cognitive control. Neuron 69: 680-694.
31. Di Chiara G, Imperato A, (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85: 5274-5278.
32. Drutel G, Peitsaro N, Karlstedt K, Wieland K, Smit MJ, Timmerman H, et al. (2001). Identification of rat H3 receptor isoforms with different brain expression and signaling properties. Mol Pharmacol 59: 1-8.
33. Dworkin SI, Guerin GF, Co C, Goeders NE, Smith JE, (1988). Lack of an effect of 6-hydroxydopamine lesions of the nucleus accumbens on intravenous morphine self-administration. Pharmacol Biochem Behav 30: 1051-1057.
34. Ericson H, Watanabe T, Kohler C, (1987). Morphological analysis of the tuberomammillary nucleus in the rat brain: delineation of subgroups with antibody against L-histidine decarboxylase as a marker. J Comp Neurol 263: 1-24.
35. Everitt BJ, Robbins TW, (2005). Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8: 1481-1489.
36. Feltenstein MW, See RE, (2008). The neurocircuitry of addiction: an overview. Br J Pharmacol 154: 261-274.
37. Feng J, Nestler EJ, (2010). MeCP2 and drug addiction. Nat Neurosci 13: 1039-1041.
38. Ferrada C, Ferre S, Casado V, Cortes A, Justinova Z, Barnes C, et al. (2008). Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function. Neuropharmacology 55: 190-197.
39. Ferrada C, Moreno E, Casado V, Bongers G, Cortes A, Mallol J, et al. (2009). Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors. Br J Pharmacol 157: 64-75.
40. Fletcher PJ, (1998). A comparison of the effects of risperidone, raclopride, and ritanserin on intravenous self-administration of d-amphetamine. Pharmacol Biochem Behav 60: 55-60.
41. Fox GB, Esbenshade TA, Pan JB, Radek RJ, Krueger KM, Yao BB, et al. (2005). Pharmacological properties of ABT-239[4-(2-{2-[(2R)-2- methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzon itrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist. J Pharmacol Exp Ther 313: 176-190.
42. Freeman WM, Patel KM, Brucklacher RM, Lull ME, Erwin M, Morgan D, et al. (2008). Persistent alterations in mesolimbic gene expression with abstinence from cocaine self-administration. Neuropsychopharmacology 33: 1807-1817.
43. Galici R, Rezvani AH, Aluisio L, Lord B, Levin ED, Fraser I, et al. (2011). Jnj-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats. Inflamm Res 60: S333-S333.
44. Gerrits MA, Van Ree JM, (1996). Effect of nucleus accumbens dopamine depletion on motivational aspects involved in initiation of cocaine and heroin self-administration in rats. Brain Res 713: 114-124.
45. Giannoni P, Passani MB, Nosi D, Chazot PL, Shenton FC, Medhurst AD, et al. (2009). Heterogeneity of histaminergic neurons in the tuberomammillary nucleus of the rat. Eur J Neurosci 29: 2363-2374.
46. Giannoni P, Medhurst AD, Passani MB, Giovannini MG, Ballini C, Corte LD, et al. (2010). Regional differential effects of the novel histamine H3 receptor antagonist 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N- methyl-3-pyridine carboxamide hydrochloride (GSK189254) on histamine release in the central nervous system of freely moving rats. J Pharmacol Exp Ther 332: 164-172.
47. Giovannini MG, Efoudebe M, Passani MB, Baldi E, Bucherelli C, Giachi F, et al. (2003). Improvement in fear memory by histamine-elicited ERK2 activation in hippocampal CA3 cells. J Neurosci 23: 9016-9023.
48. Grace AA, Floresco SB, Goto Y, Lodge DJ, (2007). Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 30: 220-227.
49. Groman SM, Jentsch JD, (2012). Cognitive control and the dopamine D(2)-like receptor: a dimensional understanding of addiction. Depress Anxiety 29: 295-306.
50. Haas HL, Sergeeva OA, Selbach O, (2008). Histamine in the nervous system. Physiol Rev 88: 1183-1241.
51. Haensel SM, Mos J, Olivier B, Slob AK, (1991). Sex behavior of male and female Wistar rats affected by the serotonin agonist 8-OH-DPAT. Pharmacol Biochem Behav 40: 221-228.
52. Hikida T, Kimura K, Wada N, Funabiki K, Nakanishi S, (2010). Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior. Neuron 66: 896-907.
53. Hubner CB, Moreton JE, (1991). Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology (Berl) 105: 151-156.
54. Hyman SE, Malenka RC, Nestler EJ, (2006). Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29: 565-598.
55. Im HI, Hollander JA, Bali P, Kenny PJ, (2010). MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci 13: 1120-1127.
56. Inagaki N, Toda K, Taniuchi I, Panula P, Yamatodani A, Tohyama M, et al. (1990). An analysis of histaminergic efferents of the tuberomammillary nucleus to the medial preoptic area and inferior colliculus of the rat. Exp Brain Res 80: 374-380.
57. Izzo E, Orsini C, Koob GF, Pulvirenti L, (2001). A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule. Pharmacol Biochem Behav 68: 701-708.
58. Jang IS, Rhee JS, Watanabe T, Akaike N, (2001). Histaminergic modulation of GABAergic transmission in rat ventromedial hypothalamic neurones. J Physiol 534 (Pt 3): 791-803.
59. Koob GF, Volkow ND, (2010). Neurocircuitry of addiction. Neuropsychopharmacology 35: 217-238.
60. Koob GF, Ahmed SH, Boutrel B, Chen SA, Kenny PJ, Markou A, et al. (2004). Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 27: 739-749.
61. Kwiatkowski H, (1941). Observations on the relation of histamine to reactive hyperaemia. J Physiol 100: 147-158.
62. Lammel S, Hetzel A, Hackel O, Jones I, Liss B, Roeper J, (2008). Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 57: 760-773.
63. Lammel S, Ion DI, Roeper J, Malenka RC, (2011). Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron 70: 855-862.
64. Ligneau X, Landais L, Perrin D, Piriou J, Uquen M, Denis E, et al. (2007). Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochem Pharmacol 73: 1215-1224.
65. Lintunen M, Hyytia P, Sallmen T, Karlstedt K, Tuomisto L, Leurs R, et al. (2001). Increased brain histamine in an alcohol-preferring rat line and modulation of ethanol consumption by H(3) receptor mechanisms. FASEB J 15: 1074-1076.
66. Liu X, Jernigen C, Gharib M, Booth S, Caggiula AR, Sved AF, (2010). Effects of dopamine antagonists on drug cue-induced reinstatement of nicotine-seeking behavior in rats. Behav Pharmacol 21: 153-160.
67. Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A, et al. (1999). Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol 55: 1101-1107.
68. Mahmood D, Khanam R, Pillai KK, Akhtar M, (2012). Protective effects of histamine H3-receptor ligands in schizophrenic behaviors in experimental models. Pharmacol Rep 64: 191-204.
69. Margolis EB, Lock H, Chefer VI, Shippenberg TS, Hjelmstad GO, Fields HL, (2006). Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proc Natl Acad Sci U S A 103: 2938-2942.
70. Martinez D, Slifstein M, Narendran R, Foltin RW, Broft A, Hwang DR, et al. (2009). Dopamine D1 receptors in cocaine dependence measured with PET and the choice to self-administer cocaine. Neuropsychopharmacology 34: 1774-1782.
71. Medhurst AD, Atkins AR, Beresford IJ, Brackenborough K, Briggs MA, Calver AR, et al. (2007). GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models. J Pharmacol Exp Ther 321: 1032-1045.
72. Mello NK, Negus SS, (1996). Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14: 375-424.
73. Monnier M, Fallert M, Battacharya IC, (1967). The waking action of histamine. Experientia 23: 21-22.
74. Moreno E, Hoffmann H, Gonzalez-Sepulveda M, Navarro G, Casado V, Cortes A, et al. (2011). Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway. J Biol Chem 286: 5846-5854.
75. Morgan RK, McAllister B, Cross L, Green DS, Kornfeld H, Center DM, et al. (2007). Histamine 4 receptor activation induces recruitment of FoxP3+ T cells and inhibits allergic asthma in a murine model. J Immunol 178: 8081-8089.
76. Motawaj M, Arrang JM, (2011). Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, modulates methamphetamine-induced sensitization in mice. Eur J Neurosci 33: 1197-1204.
77. Munzar P, Tanda G, Justinova Z, Goldberg SR, (2004). Histamine H3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release. Neuropsychopharmacology 29: 705-717.
78. Nader MA, Morgan D, Gage HD, Nader SH, Calhoun TL, Buchheimer N, et al. (2006). PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci 9: 1050-1056.
79. Nuutinen S, Karlstedt K, Aitta-Aho T, Korpi ER, Panula P, (2010). Histamine and H3 receptor-dependent mechanisms regulate ethanol stimulation and conditioned place preference in mice. Psychopharmacology (Berl) 208: 75-86.
80. Nuutinen S, Lintunen M, Vanhanen J, Ojala T, Rozov S, Panula P, (2011a). Evidence for the role of histamine H3 receptor in alcohol consumption and alcohol reward in mice. Neuropsychopharmacology 36: 2030-2040.
81. Nuutinen S, Vanhanen J, Pigni MC, Panula P, (2011b). Effects of histamine H3 receptor ligands on the rewarding, stimulant and motor-impairing effects of ethanol in DBA/2J mice. Neuropharmacology 60: 1193-1199.
82. Okuda T, Zhang D, Shao H, Okamura N, Takino N, Iwamura T, et al. (2009). Methamphetamine- and 3,4-methylenedioxymethamphetamine-induced behavioral changes in histamine H3-receptor knockout mice. J Pharmacol Sci 111: 167-174.
83. Panula P, Nuutinen S, (2011). Histamine and H3 receptor in alcohol-related behaviors. J Pharmacol Exp Ther 336: 9-16.
84. Panula P, Yang HY, Costa E, (1984). Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci U S A 81: 2572-2576.
85. Perez-Garcia C, Morales L, Cano MV, Sancho I, Alguacil LF, (1999). Effects of thioperamide on the conditioned place preference and the physical dependence induced by morphine in the rat. Pharmacol Rev Commun 10: 291-298.
86. Pettit HO, Ettenberg A, Bloom FE, Koob GF, (1984). Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology (Berl) 84: 167-173.
87. Pillot C, Heron A, Cochois V, Tardivel-Lacombe J, Ligneau X, Schwartz JC, et al. (2002). A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain. Neuroscience 114: 173-193.
88. Pycock CJ, Carter CJ, Kerwin RW, (1980). Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites of the rat. J Neurochem 34: 91-99.
89. Ralph RJ, Caine SB, (2005). Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice. J Pharmacol Exp Ther 312: 733-741.
90. Ralph-Williams RJ, Lehmann MV, Otero CV, Low MJ, Geyer MA, (2002). Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice. J Neurosci 22: 9604-9611.
91. Robinson TE, Berridge KC, (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18: 247-291.
92. Robinson TE, Gorny G, Mitton E, Kolb B, (2001). Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 39: 257-266.
93. Robison AJ, Nestler EJ, (2011). Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 12: 623-637.
94. Russo SJ, Dietz DM, Dumitriu D, Morrison JH, Malenka RC, Nestler EJ, (2010). The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends Neurosci 33: 267-276.
95. Ryu JH, Yanai K, Iwata R, Ido T, Watanabe T, (1994). Heterogenous distribution of histamine H3, dopamine D1 and dopamine D2 receptors in rat brain. Neuroreport 5: 621-624.
96. Schenk S, Gittings D, Colussi-Mas J, (2011). Dopaminergic mechanisms of reinstatement of MDMA-seeking behaviour in rats. Br J Pharmacol 162: 1770-1780.
97. Schlicker E, Werthwein S, Zentner J, (1999). Histamine H3 receptor-mediated inhibition of noradrenaline release in the human brain. Fundam Clin Pharmacol 13: 120-122.
98. Schmidt HD, Sangrey GR, Darnell SB, Schassburger RL, Cha JH, Pierce RC, et al. (2012). Increased brain-derived neurotrophic factor (BDNF) expression in the ventral tegmental area during cocaine abstinence is associated with increased histone acetylation at BDNF exon I-containing promoters. J Neurochem 120: 202-209.
99. Shaham Y, Shalev U, Lu L, de Wit H, Stewart J, (2003). The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 168: 3-20.
100. Southam E, Cilia J, Gartlon JE, Woolley ML, Lacroix LP, Jennings CA, et al. (2009). Preclinical investigations into the antipsychotic potential of the novel histamine H-3 receptor antagonist GSK207040. Psychopharmacology (Berl) 201: 483-494.
101. Takahashi H, Matsui H, Camerer C, Takano H, Kodaka F, Ideno T, et al. (2010). Dopamine D(1) receptors and nonlinear probability weighting in risky choice. J Neurosci 30: 16567-16572.
102. Takahashi H, Yamada M, Suhara T, (2012). Functional significance of central D1 receptors in cognition: beyond working memory. J Cereb Blood Flow Metab 32: 1248-1258.
103. Torrent A, Moreno-Delgado D, Gomez-Ramirez J, Rodriguez-Agudo D, Rodriguez-Caso C, Sanchez-Jimenez F, et al. (2005). H3 autoreceptors modulate histamine synthesis through calcium/calmodulin- and cAMP-dependent protein kinase pathways. Mol Pharmacol 67: 195-203.
104. Tzschentke TM, (1998). Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56: 613-672.
105. Tzschentke TM, (2007). Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12: 227-462.
106. Ungless MA, Grace AA, (2012). Are you or aren't you? Challenges associated with physiologically identifying dopamine neurons. Trends Neurosci 35: 422-430.
107. UNODC (2010). World Drug Report 2010. edn. United Nations Publication: Vienna.
108. Usiello A, Baik JH, Rouge PF, Picetti R, Dierich A, LeMeur M, et al. (2000). Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408: 199-203.
109. White T, (1959). Formation and catabolism of histamine in brain tissue in vitro. J Physiol 149: 34-42.
110. Wise RA, Bozarth MA, (1987). A psychomotor stimulant theory of addiction. Psychol Rev 94: 469-492.
111. Wise RA, Rompre PP, (1989). Brain dopamine and reward. Annu Rev Psychol 40: 191-225.
112. Wise RA, Newton P, Leeb K, Burnette B, Pocock D, Justice JBJ, (1995). Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats. Psychopharmacology (Berl) 120: 10-20.
113. Yokel RA, Wise RA, (1976). Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology (Berl) 48: 311-318.